Digoxin for Rheumatic Heart Disease, Pregnant and Postpartum Support for Medical Trainees, Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta, and more episode artwork

EPISODE · May 15, 2026 · 11 MIN

Digoxin for Rheumatic Heart Disease, Pregnant and Postpartum Support for Medical Trainees, Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta, and more

from JAMA Editors' Summary

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from May 9-15, 2026.

Episode metadata supplied by the publisher feed · Published May 15, 2026

Embed this episode

NOW PLAYING

Digoxin for Rheumatic Heart Disease, Pregnant and Postpartum Support for Medical Trainees, Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta, and more

0:00 11:30

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Editors' Summary?

This episode is 11 minutes long.

When was this JAMA Editors' Summary episode published?

This episode was published on May 15, 2026.

Can I download this JAMA Editors' Summary episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!